BiopharmaTrend: Where Tech Meets Bio

BioPharmaTrend

AI report cover

Latest News

NVIDIA Releases Agentic AI Blueprint for Literature …

NVIDIA Releases Agentic AI Blueprint for Literature Review and Target Discovery

NVIDIA has released a new AI-driven workflow, the Biomedical AI-Q Research Agent Developer Blueprint, designed to accelerate the early phases of drug discovery by automating … Read More

Nabla Raises $70M Series C to Expand …

Nabla Raises $70M Series C to Expand Agentic AI Platform for Clinical Workflows

Nabla, developer of a widely adopted AI assistant used by over 130 healthcare organizations, has raised a $70 million Series C round led by HV … Read More

Axiom Bio Releases Human Liver Toxicity Dataset …

Axiom Bio Releases Human Liver Toxicity Dataset with 130,000 Compounds to Advance AI-based Toxicity Prediction

San Francisco-based startup Axiom Bio, previously backed by $15 million in seed funding from investors including Amplify Partners, Dimension Capital, and Zetta Ventures, has released … Read More

Xaira Publishes Largest Public Perturb-seq Atlas to Advance Virtual Cell Modeling

Agenus and Noetik Partner to Develop AI-Based Biomarkers Using Virtual Cell Models

Isomorphic Labs Appoints Ben Wolf as Chief Medical Officer, Expands to U.S. Hub in Cambridge

Ryght AI Raises $3M to Automate Clinical Trial Site Activation with Agentic AI

AstraZeneca Signs $5.3B AI Drug Discovery Deal with CSPC for Chronic Disease Programs

Insilico Medicine Completes Oversubscribed Series E, Bringing Total Funding to $123 Million

Read latest news ›››

Latest Insights

Combination Therapies May Be the Future of …

by Andreas Dreps, Bea Mann, PhD

Combination Therapies May Be the Future of Oncology – How Can We Navigate Development Challenges Today?

The field of oncology is experiencing a proliferation of cancer therapies. In 2024 alone, the U.S. Food and Drug Administration (FDA) issued more than 60 … Read More

Marking the Path Ahead: Integrating Oncology Biomarkers …

by Bea Mann, PhD

Marking the Path Ahead: Integrating Oncology Biomarkers Into Clinical Development

In recent years, therapeutic capabilities in oncology have grown dramatically, with a vast array of advanced treatments progressing through clinical trials and onto the market. … Read More

AI-Based Next-Generation-Phenotyping for Rare Disease Diagnosis

by Adele Ruder, Alexander Hustinx, Louise von Stechow

How AI, Graphs, and GraphRAG Are Set to Revolutionize Alzheimer's Gene Research and Treatment

by Dominik Tomicevic

Novotech Report: Over 800 Global IPF Trials Since 2020, Led by Asia-Pacific

by BiopharmaTrend

Report: Nearly 80% of Life Sciences Leaders Considering Virtual Models for Observational Research

by BiopharmaTrend

AI in Drug Safety: From Concept to Reality, The Industry's Path Forward

by Dr. Karthik Muthusamy

Marking the Path Ahead: Integrating Oncology Biomarkers Into Clinical Development

by Bea Mann, PhD

Combination Therapies May Be the Future of Oncology – How Can We Navigate Development Challenges Today?

by Andreas Dreps, Bea Mann, PhD

The Future of Advanced Therapeutics: Opportunities and Challenges

by Sai Bhamidipati

Read all insights ›››

From Our Partners

Read All ›››

Unlocking Interoperability with AI: How This Company …

Sponsored by Trialize

Unlocking Interoperability with AI: How This Company is Building a New Framework for Clinical Trials

This AI Startup Joins Forces With NVIDIA's …

Sponsored by RECEPTOR.AI

This AI Startup Joins Forces With NVIDIA's BioNeMo to Boost Drug Discovery

How AI Empowers Biomarker-Driven Clinical Trials

Sponsored by Lantern Pharma

How AI Empowers Biomarker-Driven Clinical Trials

Chemistry CROs at a Crossroads: How SpiroChem …

Sponsored by SpiroChem

Chemistry CROs at a Crossroads: How SpiroChem Is Adapting to Market Shifts in 2025 and Beyond

Partner Events

View all events ›››

22nd BioPharma Drug Discovery Nexus Conference Belgium

22nd BioPharma Drug Discovery Nexus Conference Belgium

Event Date: April 29, 2026 - April 29, 2026

Location: Belgium (Brussels, Holiday Inn)

Website: Link

Interactive Response Technologies 2025

Interactive Response Technologies 2025

Event Date: Oct. 14, 2025 - Oct. 15, 2025

Location: United States of America (The Westin Copley Place, Boston, MA)

Website: Link

RNA Leaders USA Congress

RNA Leaders USA Congress

Event Date: Sept. 10, 2025 - Sept. 11, 2025

Location: United States of America (Boston Exhibition & Convention Center)

Website: Link

The 12th Aging Research & Drug Discovery Meeting

The 12th Aging Research & Drug Discovery Meeting

Event Date: Aug. 25, 2025 - Aug. 29, 2025

Location: Denmark (Ceremonial Hall, University of Copenhagen)

Website: Link

Case Studies

Read All ›››

Application of AI-driven Xanthos Platform for Designing …

Sponsored by Celeris Therapeutics

Application of AI-driven Xanthos Platform for Designing Protein Degraders

Revolutionizing Clinical Trials: How AI and Automation …

Sponsored by Trialize

Revolutionizing Clinical Trials: How AI and Automation Reduced Study Build Time from Months to Days

AI Becomes a Drop-in Replacement for Docking

Sponsored by RECEPTOR.AI

AI Becomes a Drop-in Replacement for Docking

Identifying High Impact Tissue Sparing E3 Ligases …

Sponsored by Kymera Therapeutics

Identifying High Impact Tissue Sparing E3 Ligases and Their Binders

Bioz Badges — Advanced Data-Widgets for Confident …

Sponsored by Bioz

Bioz Badges — Advanced Data-Widgets for Confident E-commerce

How Astellas Pharma Achieves R&D Operational Excellence …

Sponsored by Science Exchange

How Astellas Pharma Achieves R&D Operational Excellence with Science Exchange

Using End-to-End Wet Lab Automation Combined with …

Sponsored by Arctoris

Using End-to-End Wet Lab Automation Combined with Machine Learning to Industrialize Drug Discovery

Biocompare: Offline Order Attribution Analysis Helps Demonstrate …

Sponsored by Biocompare

Biocompare: Offline Order Attribution Analysis Helps Demonstrate Marketing Effectiveness

Interviews

Read All ›››

Cracking the Code of Life: An Interview …

Cracking the Code of Life: An Interview with Stef van Grieken, CEO of Cradle, on AI-Driven Protein Engineering

Democratizing Early Drug Discovery through Artificial Intelligence: …

Democratizing Early Drug Discovery through Artificial Intelligence: Interview with Syntekabio CEO Jongsun Jung

Targeted Protein Degradation: a New Approach to …

Targeted Protein Degradation: a New Approach to Small Molecule Therapeutics

This South Korean Company is at the …

This South Korean Company is at the Forefront of AI-driven Drug Discovery

Most Read

Insilico Medicine’s Generative AI Patent Provides Advantage …

Insilico Medicine’s Generative AI Patent Provides Advantage in AI Drug Discovery Race

How Big Pharma Adopts AI To Boost …

How Big Pharma Adopts AI To Boost Drug Discovery

9 Notable AI Companies in Clinical Research …

9 Notable AI Companies in Clinical Research to Watch in 2023

14 Companies Using Quantum Theory To Accelerate …

14 Companies Using Quantum Theory To Accelerate Drug Discovery (Including 2 Going Public)

	
		OSZAR »